It will also present evidence defining the role of B-type natriuretic peptide in the differential diagnosis of dyspnea, prognosis after cardiac events, and in monitoring HF drug therapy.

We investigated whether serum B-type Natriuretic Peptide (BNP) is a useful biomarker to evaluate the course of PPHN and effectiveness of treatment. Design/methods: 24 patients with PPHN were treated.

Brain natriuretic peptide (BNP), first discovered in porcine brain, is principally produced by the heart. Unlike atrial natriuretic peptide (ANP), BNP is largely derived from the ventricles.